Scott-edil Advance Research Laboratories & Educati Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Scott-edil Advance Research Laboratories & Educati Pharmaceutical Export Portfolio Dataset — 4 Products, $7.9M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Scott-edil Advance Research Laboratories & Educati — Pharmaceutical Exporter Profile (2026) | 4 Products, $7.9M Trade | TransData Nexus

Scott-edil Advance Research Laboratories & Educati

Indian Pharmaceutical Exporter · Advanced Antibiotics Specialist · $7.9M Total Trade · DGFT Verified

Scott-edil Advance Research Laboratories & Educati is an Indian pharmaceutical exporter with a total trade value of $7.9M across 4 products in 1 therapeutic categories. Based on 294 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Ceftriaxone ($5.0M), Cefuroxime ($2.2M), Cefpodoxime ($497.8K).

Scott-edil Advance Research Laboratories & Educati — Export Portfolio & Destination Treemap

Scott-edil Advance Research Laboratories & Educati pharmaceutical export portfolio — 4 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Scott-edil Advance Research Laboratories & Educati? — Company Overview & Market Position

Scott-Edil Advance Research Laboratories & Education Limited (SEARLE) is an Indian pharmaceutical company specializing in the manufacturing of generic formulations, particularly antibiotics. Incorporated on June 4, 2009, under the Corporate Identification Number (CIN) U24232CH2009PLC031649, the company is headquartered in Chandigarh, India. As of the latest available data, SEARLE has an authorized capital of ₹40 crore and a paid-up capital of ₹39.48 crore. The company operates as a public limited entity, with a promoter holding of 92.83% and public shareholders holding 4.10% as of the fiscal year 2024. SEARLE's product portfolio includes a range of pharmaceutical formulations such as tablets, capsules, syrups, and injections, with a focus on cephalosporin and beta-lactam antibiotics.

What Does Scott-edil Advance Research Laboratories & Educati Export? — Product Portfolio Analysis

Top Products by Export Value

1Ceftriaxone$5.0M 2Cefuroxime

Product Portfolio — Top 4 by Export Value

Scott-edil Advance Research Laboratories & Educati exports 4 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Ceftriaxone	Advanced Antibiotics	$5.0M	163	1.7%	12
2	Cefuroxime	Advanced Antibiotics	$2.2M	84	1.7%	11
3	Cefpodoxime	Advanced Antibiotics	$497.8K	35	0.6%	10
4	Ceftazidime	Advanced Antibiotics	$225.7K	12	2.1%	5

Scott-edil Advance Research Laboratories & Educati exports 4 pharmaceutical products across 1 therapeutic categories with a total export value of $7.9M. The top category is Advanced Antibiotics (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Scott-edil Advance Research Laboratories & Educati — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

SEARLE operates a manufacturing facility located in Baddi, Himachal Pradesh, India. This plant specializes in the production of various pharmaceutical formulations, including tablets, capsules, dry powder and liquid injectables, dry syrups, oral liquids, ophthalmic solutions, ointments, creams, gels, dietary protein, and food supplements. The facility is certified by the World Health Organization for Good Manufacturing Practices (WHO GMP), ensuring adherence to international quality standards.

3Key Leadership

The leadership team at SEARLE comprises several key individuals:

Vaishali Aggarwal: Managing Director, appointed on June 4, 2009.

Sanjeev Kumar: Director, appointed on June 4, 2009.

Munish Kumar: Director, appointed on August 1, 2017.

Prince Vohra: Chief Financial Officer (CFO), appointed on October 11, 2021.

Balram Krishan: Additional Director, appointed on January 11, 2010.

Pushkin Sharma: Director, appointed on October 18, 2017.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Scott-edil Advance Research Laboratories & Educati Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

SEARLE's presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is not explicitly detailed in the available sources. The company's manufacturing facility in Baddi, Himachal Pradesh, is certified by the World Health Organization for Good Manufacturing Practices (WHO GMP), which is a prerequisite for market access in many regulated regions. However, specific regulatory filings, approvals, and market access statuses in these countries are not provided in the available information.

2Emerging Markets

SEARLE's export data indicates a total export value of $7.9 million USD across 294 shipments, with a portfolio concentration of 100% in advanced antibiotics. The company's focus on cephalosporin and beta-lactam antibiotics positions it well for market penetration in emerging regions. While the available data does not specify the company's presence in Africa, Latin America, or Southeast Asia, the WHO GMP certification of its manufacturing facility suggests potential for market access in these regions.

3Geographic Strategy

Scott-edil Advance Research Laboratories & Educati — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding SEARLE's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not available in the provided sources. The company's manufacturing facility in Baddi, Himachal Pradesh, is WHO GMP certified, which is a prerequisite for market access in many regulated regions. However, without explicit FDA approvals or registrations, SEARLE's direct market access in the United States remains uncertain.

2WHO & EU GMP

SEARLE's manufacturing facility in Baddi, Himachal Pradesh, is certified by the World Health Organization for Good Manufacturing Practices (WHO GMP), ensuring adherence to international quality standards. The available information does not specify whether the facility holds European Union Good Manufacturing Practice (EU GMP) certification or European Directorate for the Quality of Medicines & HealthCare (EDQM) status. Obtaining EU GMP certification would enhance SEARLE's credibility and facilitate market access within the European Union.

3CDSCO & Indian Regulatory

Scott-edil Advance Research Laboratories & Educati — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

SEARLE operates in the competitive and fragmented pharmaceutical industry, focusing on the manufacturing of generic formulations, particularly antibiotics. The company's product portfolio includes a range of pharmaceutical formulations such as tablets, capsules, syrups, and injections, with a focus on cephalosporin and beta-lactam antibiotics. While specific market share data is not available, SEARLE's emphasis on contract manufacturing for domestic and foreign pharmaceutical companies, as well as government entities, positions it as a significant player in the generic pharmaceutical sector.

2Key Differentiators

SEARLE's key differentiators include its specialization in the manufacturing of generic formulations, particularly antibiotics, and its focus on contract manufacturing for domestic and foreign pharmaceutical companies, as well as government entities. The company's manufacturing facility in Baddi, Himachal Pradesh, is certified by the World Health Organization for Good Manufacturing Practices (WHO GMP), ensuring adherence to international quality standards. These factors contribute to SEARLE's competitive advantage in the pharmaceutical industry.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Scott-edil Advance Research Laboratories & Educati as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

SEARLE's manufacturing facility in Baddi, Himachal Pradesh, is certified by the World Health Organization for Good Manufacturing Practices (WHO GMP), ensuring adherence to international quality standards. The company's focus on contract manufacturing for domestic and foreign pharmaceutical companies, as well as government entities, indicates a reliable track record in fulfilling large-scale production requirements. However, specific data on export volume and consistency, as well as other reliability indicators, are not available in the provided sources.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

TransData Nexus Research · FDA, WHO, EMA regulatory databasesMar 2026

Frequently Asked Questions — Scott-edil Advance Research Laboratories & Educati

How many pharmaceutical products does Scott-edil Advance Research Laboratories & Educati export from India?

Scott-edil Advance Research Laboratories & Educati exports 4 pharmaceutical products across 1 therapeutic categories. The top exports are Ceftriaxone ($5.0M), Cefuroxime ($2.2M), Cefpodoxime ($497.8K), Ceftazidime ($225.7K). Total export value is $7.9M.

What is Scott-edil Advance Research Laboratories & Educati's total pharmaceutical export value?

Scott-edil Advance Research Laboratories & Educati's total pharmaceutical export value is $7.9M, based on 294 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Scott-edil Advance Research Laboratories & Educati cover?

Scott-edil Advance Research Laboratories & Educati exports across 1 therapeutic categories. The largest are Advanced Antibiotics (100.0%, 4 products).

Get Full Scott-edil Advance Research Laboratories & Educati Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.